JP2004537291A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004537291A5 JP2004537291A5 JP2002592480A JP2002592480A JP2004537291A5 JP 2004537291 A5 JP2004537291 A5 JP 2004537291A5 JP 2002592480 A JP2002592480 A JP 2002592480A JP 2002592480 A JP2002592480 A JP 2002592480A JP 2004537291 A5 JP2004537291 A5 JP 2004537291A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- compound
- polynucleotide
- binds
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920001184 polypeptide Polymers 0.000 claims 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims 19
- 238000000034 method Methods 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 12
- 102000040430 polynucleotide Human genes 0.000 claims 9
- 108091033319 polynucleotide Proteins 0.000 claims 9
- 239000002157 polynucleotide Substances 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 7
- 239000003085 diluting agent Substances 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 239000013604 expression vector Substances 0.000 claims 4
- 238000003556 assay Methods 0.000 claims 3
- 238000004458 analytical method Methods 0.000 claims 2
- 238000000159 protein binding assay Methods 0.000 claims 2
- 238000003259 recombinant expression Methods 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000000975 co-precipitation Methods 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 238000001400 expression cloning Methods 0.000 claims 1
- 238000005194 fractionation Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 238000001262 western blot Methods 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29338101P | 2001-05-24 | 2001-05-24 | |
| PCT/US2002/016387 WO2002095017A1 (en) | 2001-05-24 | 2002-05-23 | Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004537291A JP2004537291A (ja) | 2004-12-16 |
| JP2004537291A5 true JP2004537291A5 (enExample) | 2005-12-22 |
Family
ID=23128847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002592480A Withdrawn JP2004537291A (ja) | 2001-05-24 | 2002-05-23 | 新規混合系統キナーゼ（７）（ｍｌｋ７）ポリペプチド、それをコードするポリヌクレオチド、およびそれらの使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040185460A1 (enExample) |
| EP (1) | EP1402009A4 (enExample) |
| JP (1) | JP2004537291A (enExample) |
| CA (1) | CA2448102A1 (enExample) |
| MX (1) | MXPA03010706A (enExample) |
| WO (1) | WO2002095017A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005103240A1 (en) * | 2004-04-24 | 2005-11-03 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1) |
| US9061009B2 (en) * | 2007-06-08 | 2015-06-23 | University Of Massachusetts | Mixed lineage kinases and metabolic disorders |
| EP2602993A1 (en) * | 2011-12-08 | 2013-06-12 | Research In Motion Limited | Apparatus and associated method for face tracking in video conference and video chat communications |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) * | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4879236A (en) * | 1984-05-16 | 1989-11-07 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US6514745B1 (en) * | 1993-07-19 | 2003-02-04 | The Regents Of The University Of California | Oncoprotein protein kinase |
| US5534426A (en) * | 1993-07-19 | 1996-07-09 | The Regents Of The University Of California | Oncoprotein protein kinase |
| US5554523A (en) * | 1994-03-01 | 1996-09-10 | Children's Hospital Of Philadelphia | Nucleic acid sequences encoding human leucine-zipper protein-kinase |
| US5817479A (en) * | 1996-08-07 | 1998-10-06 | Incyte Pharmaceuticals, Inc. | Human kinase homologs |
| AU2001234544A1 (en) * | 2000-01-25 | 2001-08-07 | Sugen, Inc. | Novel human protein kinases and protein kinase-like enzymes |
| AU2002303258A1 (en) * | 2001-04-06 | 2002-10-28 | Incyte Genomics, Inc. | Kinases and phosphatases |
| AU2003225535A1 (en) * | 2002-01-31 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating cancer |
-
2002
- 2002-05-23 CA CA002448102A patent/CA2448102A1/en not_active Abandoned
- 2002-05-23 WO PCT/US2002/016387 patent/WO2002095017A1/en not_active Ceased
- 2002-05-23 JP JP2002592480A patent/JP2004537291A/ja not_active Withdrawn
- 2002-05-23 MX MXPA03010706A patent/MXPA03010706A/es unknown
- 2002-05-23 US US10/478,068 patent/US20040185460A1/en not_active Abandoned
- 2002-05-23 EP EP02731920A patent/EP1402009A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005120106A5 (enExample) | ||
| CA2180425A1 (en) | Purified primate ctla-8 antigens and related reagents | |
| JP2002534122A5 (enExample) | ||
| CA2453528A1 (en) | Novel fusion proteins and assays for molecular binding | |
| RU2007101725A (ru) | Идентификация инфицированных вирусом и вакцинированных вирусом организмов | |
| CN112079906A (zh) | 一种高稳定性新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒 | |
| JP2003534013A5 (enExample) | ||
| WO2000009730A3 (en) | Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins | |
| JP2024178283A5 (enExample) | ||
| CA2343979A1 (en) | Human interleukin-b50, therapeutic uses | |
| JP2010523994A5 (enExample) | ||
| CN103267841B (zh) | 一种利用亲和素结合肽与亲和素结合的原理制备elisa酶标抗原的方法 | |
| JP2004537291A5 (enExample) | ||
| JP2012522522A5 (enExample) | ||
| JPH1066585A5 (enExample) | ||
| US7255859B1 (en) | Monoclonal antibodies against the epitope YPYDVPDYA, a process for their production and their use | |
| CN103275194A (zh) | 一种猪血清中猪传染性胃肠炎病毒或猪呼吸道冠状病毒抗体的抗原及其elisa检测方法 | |
| JP2002536989A5 (enExample) | ||
| JP6808178B2 (ja) | ヒトパルボウイルスｂ１９抗原および抗体の同時検出方法及びキット | |
| CN103454245B (zh) | 一种定性定量检测植物激素活性赤霉素的方法及其专用芯片 | |
| CN114805565B (zh) | 一种丙型肝炎病毒e2蛋白的单域抗体hcv-e2及其应用 | |
| CN115932255A (zh) | 一种山羊痘病毒抗体荧光微球免疫层析检测试剂盒及其制备方法 | |
| CN101759788A (zh) | 分子设计的结合藻蓝胆素的藻蓝蛋白β亚基类荧光蛋白及其应用 | |
| JP2005502324A5 (enExample) | ||
| JP2009542243A5 (enExample) |